1887

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Corona Virus-2 (SARS-CoV-2). The disease was first identified in December 2019 in Wuhan, the capital of China's Hubei province, and has since spread globally, resulting in the ongoing 2019–2020 corona virus pandemic. SARS-CoV-2 is closely related to the original SARS-CoV. It is thought to have a zoonotic origin. The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing or talking. People may also become infected by touching a contaminated surface and then touching their face. COVID-19 patients currently remain the primary source of infection. An epidemiological survey indicated that the general population is susceptible to SARS-CoV-2. The spectrum of this disease ranges from mild to life-threatening. Fever is the most common symptom, although older people and those with comorbidities may experience fever later in the disease. Other common symptoms include cough, loss of appetite, fatigue, shortness of breath, sputum production, and muscle and joint pains. Symptoms such as nausea, vomiting and diarrhea have been observed in varying percentages. Some cases might progress promptly to acute respiratory distress syndrome (ARDS) and/or multiple organ function failure. Asymptomatic carriers and those in the incubation period may also be infectious.

To determine the epidemiological and clinical characteristics of patients presenting with COVID-19 at the screening clinic of a tertiary care hospital in Peshawar, Pakistan.

In this descriptive study, we analysed data of patients presenting to a newly established Covid-19 screening clinic in Rehman Medical Institute. Anyone who reported with new onset fever and/or cough was tested for SARS-CoV-2 in the screening clinic. We documented and analysed demographic, epidemiological and clinical characteristics, which included age, sex, travel history, clinical features, comorbidities and laboratory data of patients confirmed by real-time reverse-transcription (RT)-PCR at Rehman Medical Institute, Peshawar, Pakistan from 15 March till 21 April 2020. Paired specimens of throat swabs and nasal swabs were obtained from 845 patients, ribonucleic acid (RNA) was extracted and tested for SARS-CoV-2 by the RT-PCR assay.

A total of 845 specimens were taken as described above. The positive rate for SARS-CoV-2 was about 14.3%. Male and older population had a significantly higher positive rate. Of the 121 patients infected with SARS-CoV-2, the mean age was 43.19 years (, 17.57) and the infections were more frequent among male gender accounting for 85 (70.25 %) patients. Common symptoms included fever (88 patients, 72 %), cough (72 patients, 59.5 %) and shortness of breath (69 patients, 57 %). Twenty-two (18 %) patients had recent travel history outside Pakistan in the previous 14 days, the majority of whom had returned back from Saudi Arabia.

In this single-centre, prospective, descriptive study, fever, cough and shortness of breath were the most common symptoms. Old age (>50 years), chronic underlying comorbidities and travel history may be risk factors. Therefore, we concluded that viral nucleic acid amplification tests (NAAT) played an important role in identifying SARS-CoV-2 infection in a screening clinic, which helped with isolation and cohorting of these patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001231
2020-08-12
2020-09-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/8/1114.html?itemId=/content/journal/jmm/10.1099/jmm.0.001231&mimeType=html&fmt=ahah

References

  1. China Wuhan Municipal Health Commission Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation 31 Dec 2019 [in Chinese]. 2020 [cited 2020 Feb 20]. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989 .
  2. Zhu N, Zhang D, Wang W, Li X, Yang B et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–733 [CrossRef][PubMed]
    [Google Scholar]
  3. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506 [CrossRef][PubMed]
    [Google Scholar]
  4. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323:1061–1069 [CrossRef][PubMed]
    [Google Scholar]
  5. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91:157–160 [CrossRef][PubMed]
    [Google Scholar]
  6. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report – 98. 2020 [cited 2020 Apr 27]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ .
  7. WMHC Wuhan Municipal Health and Health Commission’s Briefing on the Current Pneumonia Epidemic Situation in Our City. 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Accessed 1 Feb 2020.
  8. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–273 [CrossRef][PubMed]
    [Google Scholar]
  9. Wu A, Peng Y, Huang B, Ding X, Wang X et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27:325–328 [CrossRef][PubMed]
    [Google Scholar]
  10. Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB et al. Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens. J Virol 2016; 90:7415–7428 [CrossRef][PubMed]
    [Google Scholar]
  11. Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016; 92:235–250 [CrossRef][PubMed]
    [Google Scholar]
  12. Jeong JH, Kim KH, Jeong SH, Park JW, Lee SM et al. Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses. J Med Virol 2014; 86:2122–2127 [CrossRef][PubMed]
    [Google Scholar]
  13. World Health Organization Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. January 28, 2020.
  14. Da R, Showkat A, Sa R, Ma M. The Covid-19 pandemic: a study of the current evidence in India. Purakala with Issn 0971-2143. Is An Ugc Care Journal 2020 Apr 14; 31:1–6
    [Google Scholar]
  15. Wang C, Prevalence WX. Nosocomial infection and psychological prevention of novel coronavirus infection. Chin General Pract Nurs 2020; 18:2–3
    [Google Scholar]
  16. Chen N, Zhou M, Dong X, Qu J, Gong F et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507–513 [CrossRef][PubMed]
    [Google Scholar]
  17. Li Q, Guan X, Wu P, Wang X, Zhou L et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382:1199–1207 [CrossRef][PubMed]
    [Google Scholar]
  18. Yang J, Zheng Y, Gou X, Pu K, Chen Z et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Inf Dis 2020
    [Google Scholar]
  19. Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 2019; 56:308–321 [CrossRef][PubMed]
    [Google Scholar]
  20. Johnson HD, Sholcosky D, Gabello K, Ragni R, Ogonosky N. Sex differences in public restroom handwashing behavior associated with visual behavior prompts. Percept Mot Skills 2003; 97:805–810 [CrossRef][PubMed]
    [Google Scholar]
  21. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000; 49:147–152[PubMed]
    [Google Scholar]
  22. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395:514–523 [CrossRef][PubMed]
    [Google Scholar]
  23. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; 382:970–971 [CrossRef][PubMed]
    [Google Scholar]
  24. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. The Lancet 2015; 386:995–1007 [CrossRef]
    [Google Scholar]
  25. Patel A, Jernigan DB. 2019-nCoV CDC Response Team Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:140–146 [CrossRef][PubMed]
    [Google Scholar]
  26. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis 2020 Apr 10; 90: [CrossRef]
    [Google Scholar]
  27. Leung WK, To K-F, Chan PKS, Chan HLY, Wu AKL et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003; 125:1011–1017 [CrossRef][PubMed]
    [Google Scholar]
  28. Chinese Academy of Sciences Wuhan coronavirus has strong ability to infect humans. Press release. Jan 21; 2020
  29. Hu S, Gao R, Liu L, ZHU M, WANG W et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circulation J 2019; 34:209
    [Google Scholar]
  30. Liu M, Liu S-W, Wang L-J, Bai Y-M, Zeng X-Y et al. Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study. Diabetes Metab 2019; 45:286–293 [CrossRef][PubMed]
    [Google Scholar]
  31. Fang Y, Zhang H, Xie J, Lin M, Ying L et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 2020200432 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001231
Loading
/content/journal/jmm/10.1099/jmm.0.001231
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error